← Open Payments lookup

MANILA PILLAI: Open Payments

NPI 1942739784 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$401 in 18 payments from 8 companies in 2025. Trend: 2023 $0 · 2024 $162 · 2025 $401

Food & beverage: $401
CompanyPaymentsAmount
Novartis Pharmaceuticals Corporation9$206
Daiichi Sankyo Inc.2$58
Eisai Inc.1$33
Adaptive Biotechnologies Corporation2$29
Regeneron Healthcare Solutions, Inc.1$24
Janssen Biotech, Inc.1$20
Genmab U.S., Inc.1$16
Exelixis Inc.1$16

Products named: Fabhalta, SCEMBLIX, Vanflyta, Lenvima, clonoSEQ, LIBTAYO, Epkinly, CABOMETYX.

Industry payments across TX — which companies pay providers there.